← Portfolio Scout

Portfolio company

Cortexyme

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Digital Health

About

The company develops small-molecule therapeutics targeting bacterial pathogens to treat neurodegenerative diseases and rare skeletal conditions for patients with high unmet clinical needs.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies